Label

How We Work

Grant

Back

Print

Vedantra Pharmaceuticals, Inc.


October 2012
to develop an efficacious vaccine against malaria using novel nanoparticle-based technologies termed Interbilayer-Crosslinked Multilamellar Vesicles (ICMVs) and malarial antigens
$1,350,938
0
Discovery and Translational Sciences
Global Health
Cambridge, Massachusetts

Visit Our Blog